LEX Diagnostics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

LEX Diagnostics General Information

Description

Manufacturer of point-of-care molecular diagnostics systems intended for use in clinics, pharmacies, urgent care centers, and decentralized healthcare settings. The company develops the LEX VELO PCR platform and multiplex diagnostic tests that deliver RT PCR results for respiratory infections such as COVID-19, Flu A, and Flu B in under ten minutes.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Melbourn Science Park
  • Melbourn SG8 6EE
  • England, United Kingdom
+44 01223
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Parent Company
Vertical(s)
Corporate Office
  • Melbourn Science Park
  • Melbourn SG8 6EE
  • England, United Kingdom
+44 01223

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

LEX Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore LEX Diagnostics‘s full profile, request access.

Request a free trial

LEX Diagnostics Patents

LEX Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025242595-A1 Fluidic cartridges with component-free valves Pending 21-May-2024
EP-4433213-A1 Devices, systems, and methods for nucleic acid amplification Pending 17-Nov-2021
US-20250010304-A1 Devices, systems, and methods for nucleic acid amplification Pending 17-Nov-2021
WO-2023088952-A1 Devices, systems, and methods for nucleic acid amplification Inactive 17-Nov-2021
GB-202018985-D0 Diagnostic test cartridge, apparatus and system Inactive 02-Dec-2020
To view LEX Diagnostics’s complete patent history, request access »

LEX Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LEX Diagnostics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore LEX Diagnostics‘s full profile, request access.

Request a free trial

LEX Diagnostics FAQs

  • When was LEX Diagnostics founded?

    LEX Diagnostics was founded in 2020.

  • Where is LEX Diagnostics headquartered?

    LEX Diagnostics is headquartered in Melbourn, United Kingdom.

  • What is the size of LEX Diagnostics?

    LEX Diagnostics has 60 total employees.

  • What industry is LEX Diagnostics in?

    LEX Diagnostics’s primary industry is Diagnostic Equipment.

  • Is LEX Diagnostics a private or public company?

    LEX Diagnostics is a Private company.

  • What is the current valuation of LEX Diagnostics?

    The current valuation of LEX Diagnostics is .

  • What is LEX Diagnostics’s current revenue?

    The current revenue for LEX Diagnostics is .

  • Who are LEX Diagnostics’s investors?

    TTP Group has invested in LEX Diagnostics.

  • When was LEX Diagnostics acquired?

    LEX Diagnostics was acquired on 17-Apr-2026.

  • Who acquired LEX Diagnostics?

    LEX Diagnostics was acquired by QuidelOrtho.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process